MedTrace Logo

Examining a New Biomarker of Nicotine Use Among Pregnant Women Who Participated in the New England SCRIPT

NCT00519766 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 252

Last updated 2014-05-23

No results posted yet for this study

Summary

Smoking during pregnancy is the single most preventable cause of illness and death among mothers and infants. Because of the stigma associated with tobacco use during pregnancy, pregnant women are less likely to disclose their smoking status to doctors or study researchers. This study will evaluate the use of a new biomarker of nicotine metabolism to estimate tobacco use in a group of pregnant women who participated in the New England Smoking Cessation and Reduction in Pregnancy Trial (SCRIPT).

Conditions

  • Smoking
  • Tobacco Use Disorder

Sponsors & Collaborators

  • Memorial Hospital of Rhode Island

    lead OTHER

Principal Investigators

  • Donna R. Parker, ScD · Memorial Hospital of Rhode Island

Eligibility

Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
1997-09-30
Primary Completion
1999-03-31
Completion
2002-11-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00519766 on ClinicalTrials.gov